Details
Episindan Indications
- breast cancer
- malignant lymphomas
- soft tissue sarcoma
- stomach cancer
- liver cancer
- pancreatic cancer
- rectum cancer
- cervical cancer
- lung cancer
- ovarian cancer
- leukemia
Contradictions
Hypersensitivity to the active substance or to any of the excipients, other anthracyclines and anthracen- dions.
Breast feeding period.
Active depression of bone marrow function as a result of previous treatments with other antitumor agents or radiotherapy.
Dosage & Administration
Episindan is used intravenously or intravenously; Do not administer intramuscularly or intrathecally.
